Department of Anaesthesiology and Intensive Care Medicine, Medical University of Innsbruck, Innsbruck, Austria.
Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.
J Cardiothorac Vasc Anesth. 2024 Dec;38(12):2973-2981. doi: 10.1053/j.jvca.2024.06.036. Epub 2024 Jun 28.
Acute postoperative pain remains a major obstacle in minimally invasive cardiac surgery (MICS). Evidence of the analgesic benefit of chest wall blocks is limited. This study was designed to assess the influence of combined pectoserratus plane block plus interpectoral plane block (PSPB + IPPB) on postoperative pain and the overall benefit of analgesia compared with placebo.
A prospective, randomized, triple-blinded study was conducted.
The setting was the operating room and intensive care unit of a university hospital.
A total of 60 patients undergoing elective right-lateral MICS were enrolled.
Patients were randomly assigned to preoperative PSPB + IPPB with 30 mL of ropivacaine 0.5% or saline.
The primary endpoint was total intravenous morphine milligram equivalents administered in the first 24 hours after extubation. Secondary endpoints included the Overall Benefit of Analgesia Score (OBAS) at 24 hours after extubation and repeated Visual Analogue Scale (VAS). Values for intravenous morphine milligram equivalents administered in the first 24 hours after extubation were significantly lower (median [interquartile range]: 4.2 mg [2.1 - 7.9] v 8.3 mg [4.2 - 15.7], p = 0.025; mean difference: 6.7 mg [0.94 - 12 mg], p = 0.024, Cohen's d: 0.64 [0.09 - 1.2]). Moreover, OBAS at 24 hours and VAS after extubation were significantly lower (4.0 [3.0 - 6.0] v 7.0 [3.0 - 9.0], p = 0.043; 0.0 cm [0.0 - 2.0] v 1.5 cm [0.3 - 3.0], p = 0.030). VAS did not differ between groups at later points.
Preoperative PSPB + IPPB reduced 24-hour postextubation opioid consumption, pain at extubation, and OBAS. Given its low risk and expedient placement, it could be a helpful addition to MICS protocols. Future studies should evaluate these findings in multicenter settings and further elucidate the optimal timing of block placement.
微创心脏手术(MICS)后急性疼痛仍然是一个主要障碍。胸壁阻滞的镇痛益处证据有限。本研究旨在评估肋间肌平面阻滞联合胸肌间平面阻滞(PSPB+IPP)对术后疼痛和整体镇痛益处的影响,并与安慰剂进行比较。
前瞻性、随机、三盲研究。
大学医院手术室和重症监护病房。
共纳入 60 例行择期右侧 MICS 的患者。
患者被随机分配接受术前 PSPB+IPP,给予 30 毫升 0.5%罗哌卡因或生理盐水。
主要终点是拔管后 24 小时内静脉注射吗啡毫克当量总量。次要终点包括拔管后 24 小时的整体镇痛评分(OBAS)和重复视觉模拟评分(VAS)。拔管后 24 小时内静脉注射吗啡毫克当量值明显较低(中位数[四分位距]:4.2 毫克[2.1-7.9]比 8.3 毫克[4.2-15.7],p=0.025;平均差异:6.7 毫克[0.94-12 毫克],p=0.024,Cohen's d:0.64[0.09-1.2])。此外,拔管后 24 小时的 OBAS 和 VAS 明显较低(4.0[3.0-6.0]比 7.0[3.0-9.0],p=0.043;0.0 厘米[0.0-2.0]比 1.5 厘米[0.3-3.0],p=0.030)。两组在随后的时间点 VAS 无差异。
术前 PSPB+IPP 减少了拔管后 24 小时内的阿片类药物消耗、拔管时疼痛和 OBAS。鉴于其风险低且操作简便,它可能是 MICS 方案的有益补充。未来的研究应在多中心环境中评估这些发现,并进一步阐明阻滞放置的最佳时机。